From: Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
Indicator – ECDC code | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | P-value* | % change 2016/2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total utilisation J01 | 22.2 | 20.8 | 23.6 | 21.1 | 21.1 | 22.9 | 23.6 | 22.8 | 26.2 | 23.9 | 0.0357 | 8.3 |
J01 CE% | 0.8% | 0.8% | 0.6% | 0.7% | 0.5% | 0.7% | 0.7% | 0.9% | 1.3% | 1.3% | 0.0391 | 62.5 |
J01CR% | 18.7% | 21.7% | 20.9% | 21.3% | 30.3% | 16.9% | 16.5% | 16.6% | 17.0% | 18.5% | 0.2949 | −1.07 |
J01DD + DE% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | < 0.1% | NA | |
J01MA% | 5.2% | 5.8% | 5.3% | 5.8% | 5.6% | 5.3% | 5.0% | 5.3% | 5.3% | 5.9% | 0.9867 | 13.5 |
J01B/N% | 30.3% | 32.5% | 36.3% | 37.1% | 57.6% | 36.9% | 34.9% | 29.0% | 24. 8% | 25.8% | 0.3771 | −14.9 |